DeepMind developed a framework that highlights areas where adversarial AI is weakest, allowing defenders to prioritize ...

As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...

Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...

Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...